BlackRock Sees 2026 as the Year Retail Investors Finally Embrace Bitcoin
BlackRock's Jay Jacobs says most investors are still in the 'educational journey' phase with Bitcoin, predicting 2026 will mark a turning point for mainstream crypto adoption.
TRENDING TOPICS
1366 articles found for "investing"
BlackRock's Jay Jacobs says most investors are still in the 'educational journey' phase with Bitcoin, predicting 2026 will mark a turning point for mainstream crypto adoption.
Moderna has submitted regulatory filings for its mRNA-based seasonal flu vaccine across the US, EU, Canada, and Australia, marking a pivotal moment for the biotech company.
Tech giants are projected to invest $500 billion in AI infrastructure in 2026. TSMC, Nvidia, and data center REITs stand to benefit from the spending surge.
For the first time since 2018, all 16 S&P 500 sectors are expected to achieve positive earnings growth in 2026. Nine sectors forecast for double-digit gains.
Bitcoin retreats to $90,800 as spot BTC ETF outflows surge to their highest since November. Bernstein analysts remain bullish, forecasting $150K by year-end.
Spot Bitcoin ETFs attracted over $1.2 billion in net inflows during the first two trading days of 2026, with BlackRock and Fidelity leading the charge as Bitcoin approaches $95,000.
Sony Honda Mobility unveiled production-ready Afeela 1 at CES 2026, featuring 40 sensors and a roadmap to Level 4 autonomous driving via over-the-air updates.
The 90-day correlation between Bitcoin and the Japanese yen has surged to 0.86, the highest ever recorded. Here's what this unusual relationship means for crypto investors.
Finnish startup Verge Motorcycles announced at CES 2026 that its TS Pro will be the first production vehicle with solid-state batteries, offering 370-mile range and 10-minute charging.
Strategy (MSTR) shares jumped after MSCI announced it will not immediately exclude digital asset treasury companies from its indexes, averting potential forced selling of $15 billion.
Mobileye announced a $900 million acquisition of humanoid robotics startup Mentee Robotics at CES 2026, marking its expansion beyond autonomous vehicles into embodied AI.
BioMarin Pharmaceutical announced plans to acquire Amicus Therapeutics for $4.8 billion, creating a rare disease powerhouse and signaling a new wave of biotech consolidation.